4:02 pm Celator Pharma announces start of clinical study of CPX-351 in relapsed/refractory higher risk myelodysplastic syndrome and acute myeloid leukemia patients

more

View todays social media effects on CPXX

View the latest stocks trending across Twitter. Click to view dashboard

See who Celator is hiring next, click here to view